21.07.2011 • NewsAbbottQ2 2011Pharma

Abbott Laboratories Q2 Profit Surges 50%

Abbott Laboratories reported Wednesday a profit for the second quarter that surged 50% from last year, boosted largely by a significant tax benefit and sales growth. This was partially offset by higher operating costs, mainly for research and development.

Excluding items, ongoing earnings per share for the quarter grew 11% and topped analysts' expectations by a penny. The company also raised its ongoing earnings forecast for the full-year 2011, citing the strong performance to date.

The Abbott Park, Ill.-based drug maker reported net earnings of $1.94 billion or $1.23 per share for the second quarter, sharply higher than $1.29 billion or $0.83 per share in the prior-year quarter.

The results for the latest quarter primarily included a tax resolution benefit of $519 million or $0.33 per share, and $173 million or $0.11 per share charge related to acquisition.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.